Meeting
2022 ASCO Genitourinary Cancers Symposium
Distribution of NCCN risk classifications using MRI-ultrasound fusion versus systematic 12 core biopsies.
Authors
Ghazal Khajir
Yale School of Medicine, New Haven, CT
Ghazal Khajir , Benjamin Press , Angelique W. Levi , Preston C. Sprenkle , Michael S. Leapman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Other
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 283)
DOI
10.1200/JCO.2022.40.6_suppl.283
Abstract #
283
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
“It just makes sense to me”: Patient experiences with prostate MRI during prostate cancer active surveillance.
First Author: Ryan Sutherland
Poster
2019 Genitourinary Cancers Symposium
Increasing utilization of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.
First Author: Avinash Maganty
Poster
2019 Genitourinary Cancers Symposium
Cost implications of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.
First Author: Michelle Yu
Poster
2018 Genitourinary Cancers Symposium
Is BMI a risk factor for active surveillance progression in patients with prostate cancer diagnosed by MRI-Trus fusion biopsy?
First Author: Kareem Rayn